Iovance receives FDA clearance for IL-12 tethered TIL therapy trial

Go back to Iovance receives FDA clearance for IL-12 tethered TIL therapy trial
(NASDAQ: IOVA) Delayed: 4.38 +0.59 (15.57%)
Previous Close $3.79    52 Week High
Open $3.85    52 Week Low
Day High $4.58    P/E N/A 
Day Low $3.85    EPS
Volume 22,599,966